Method of dissolving venous Thrombi using drug containing activated Protein C
AssigneeImmuno Aktiengesellschaft
InventorsJohann Eibl, Yendra Linnau, Anton Philapitsch, Hans P. Schwarz
Life of this patent
Estimating the term…
Abstract
A method of dissolving venous thrombi using a thrombolytic, parenterally administrable drug containing activated protein C is described. The drug can be free of serum amyloid P, thrombin activity, infectious agents and antibodies against protein C and activated protein C.
Claims2
A method of dissolving venous thrombi in a patient comprising the step of administering to a patient a composition containing an effective amount of activated protein C to dissolve said venous thrombi in the presence of protein S,
- wherein said composition is free of serum amyloid thrombin activity, infectious agents, antibodies against protein C and antibodies against activated protein C.
A method of dissolving venous thrombi in a patient comprising the step of administering to a patient a composition containing an effective amount of activated protein C and lys-plasminogen to dissolve said venous thrombi in the presence of protein S,
- wherein said composition is free of serum amyloid P, thrombin activity, infectious agents, antibodies against protein C and antibodies against activated protein C.
Dependencies are inferred from the claim text.